
Can You Reverse Tooth Decay?
Most of us know that the best defense against tooth decay — or damage to the surface, or enamel, of your teeth — is to limit sugary foods and to brush and floss regularly. But once that damage has begun, or even progressed into a cavity, can you reverse it?
Online advertisements for products like cavity-undoing chewing gums and enamel-rebuilding toothpastes and tooth powders suggest that you can.
We asked experts if they work, and if it's possible to backtrack on tooth decay in the first place.
How does tooth decay happen?
Your mouth is home to both good and bad bacteria, which adhere to your teeth in a sticky layer called plaque.
The bad bacteria love to snack on sugary, starchy foods — like sweetened sodas, gummy candies, pastries and fruit juices — and then turn them into acids that, over time, may pull important minerals from your teeth.
The more these bad bacteria eat, the more acids they produce that dissolve essential minerals like calcium and phosphate, said John Featherstone, a professor emeritus of preventive and restorative dental sciences at the University of California, San Francisco, School of Dentistry.
This dissolution is called demineralization, Dr. Featherstone said, and it can weaken your enamel over months to years until it eventually caves in and forms a cavity.
How quickly this damage, or tooth decay, develops depends mostly on how much of these starchy, sugary foods you consume and how well you clean your teeth, he said.
Can you reverse tooth decay?
Tooth decay is technically reversible, but only if it is caught early, said Dr. Margherita Fontana, a researcher and professor of cariology at the University of Michigan School of Dentistry.
During the earliest stage of tooth decay, when some minerals have been lost just below the tooth's surface but a cavity has not yet formed, you (or more likely, your dentist) might notice a white — or sometimes brown or black — spot on your tooth, Dr. Fontana said.
At this point, you can reverse tooth decay by adding those important minerals back into your teeth — a process called remineralization, said Dr. Yasmi O. Crystal, an adjunct clinical professor of pediatric dentistry at the N.Y.U. College of Dentistry.
Your saliva, which contains calcium and phosphate, naturally remineralizes your teeth all the time, such as after eating a sugary snack, Dr. Crystal said.
But because most of us eat many foods that bad bacteria like, we can't depend on saliva alone to prevent or reverse decay, Dr. Featherstone said.
The easiest, cheapest and most effective way to support remineralization is to brush your teeth with toothpaste that contains fluoride, Dr. Crystal said. Fluoride not only reduces the amount of acid that bad bacteria produce, but it also helps saliva to more effectively replenish your teeth with lost minerals by attracting calcium and phosphate to them, Dr. Crystal said.
The fluoride found in most drinking water also bolsters this process, Dr. Fontana said, especially when paired with fluoride toothpaste.
This cavity-fighting duo is enough to reverse early tooth decay in most people, the experts said. But some, like those more prone to decay because they produce less saliva (such as smokers, older adults, postmenopausal women and people taking certain medications), may benefit from more concentrated fluoride products. These include prescription-strength fluoride toothpastes, as well as mouth rinses, varnishes and gels that dentists may apply during a visit or prescribe to use at home.
Chewing sugar-free gum, in addition to your regular oral hygiene routine, may also help reverse early tooth decay, Dr. Featherstone said. Chewing produces saliva that, according to the American Dental Association, contains even more enamel-building minerals than the saliva your mouth makes without stimulation from food.
Gum may also prevent tooth decay by removing food particles from your teeth, Dr. Fontana said.
Once tooth decay has caused a cavity, however, you can't reverse it and the cavity should be filled, Dr. Crystal said.
But you can stop a cavity from getting worse, said Dr. Domenick T. Zero, a professor at the Indiana University School of Dentistry. Regular dental cleanings and proper oral hygiene — brushing for at least two minutes twice a day and flossing once a day — will keep cavity-causing bacteria out of the hole and prevent it from building up on your teeth, he said.
Do those special products work?
Some limited research has suggested that some ingredients like xylitol and hydroxyapatite in products like remineralizing tooth powders, toothpastes and chewing gums may help reverse tooth decay by adding minerals back to your teeth. However, all of the experts we spoke with said there wasn't enough evidence to show that they're more effective at reversing decay than fluoride, or that they work at all.
Among the handful of small clinical trials that have looked into hydroxyapatite toothpastes, for instance, at least two were funded by the product manufacturers. Dr. Fontana also said that these products had been tested mostly on people who are not prone to cavities, so it's challenging to know how effective they may be for people who actually develop tooth decay.
'No one has shown that any of these products come even close to what fluoride toothpaste does,' she said.
As with many products you see advertised on social media, if they seem too good to be true, they probably are, Dr. Crystal said — 'there are no shortcuts.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
31 minutes ago
- Associated Press
New online tool helps women on Medicaid find prenatal care and family planning
At the University of Mississippi Medical Center, one researcher's full-time job for the past nine months has been to find out which clinics around the state offer different kinds of women's health care, and whether they accept various forms of Medicaid. The final result is a recently launched database aimed at helping women locate the nearest clinic that can offer the care they need. The work that went into creating it highlights a pervasive problem: Even making an appointment can be a barrier that keeps women from improving their lives. 'We Need to Talk' is a compilation of all Mississippi clinics offering prenatal care – specifying which ones also offer family planning, and whether they take Medicaid insurance, Medicaid waivers and see women whose Medicaid applications are pending. There is also a hotline designed to give additional support to anyone having questions or feeling overwhelmed about the process. 'Having gone through the work, it was remarkable. It wasn't easy to figure out where you should go for care,' said Dr. Thomas Dobbs, former state health officer and dean of the John D. Bower School of Population Health at UMMC, who oversaw the project. 'And that should be one of the most basic bits of information we have.' The idea was born from the recent 900% increase in babies born with syphilis, Dobbs explained, which he called a 'canary in a coal mine' signaling more danger to come. An investigation into the epidemic showed that one of the driving factors was delayed prenatal care, caused in large part by inaccessible information and concerns about cost, Dobbs said. Finding reproductive and prenatal care can be difficult for several reasons. For one thing, there are many different kinds of clinics in Mississippi, making it hard for patients to know what to search for. The list includes federally qualified health centers, county health department clinics and private OB-GYNs. Another reason is that many clinics don't specify online whether they take Medicaid, much less what their policy is on specific or temporary Medicaid coverage. Calling doesn't always guarantee patients a comprehensive or accurate answer. The new database is an initiative of UMMC's Myrlie Evers-Williams Institute – housed in the Jackson Medical Mall – which is committed to eliminating health disparities by studying the intersection of health and social issues. The institute has a clinic on site that practices what's called 'social medicine,' a key element of eliminating those disparities, the institute's executive director Victoria Gholar explained. 'If you have a patient who has asthma and they're living in a situation where mold is in their environment, it will really be hard for them to get better,' Gholar said. 'Or, if we have a patient who has to use an electronic (medical) device, and their electricity is no longer available because they weren't able to take care of their utility bill, then we try to work with them and connect them to resources that might be able to help.' The institute employs a wide range of professionals who work on health from a non-clinical standpoint, such as researchers, community engagers, social workers and registered dietitians. It hosts events like food drives and offers free support from budgeting strategies to meal preparation for those with conditions like diabetes or high blood pressure. Aside from knowing what to search for, finding clinics that accept Medicaid can also be complicated because Mississippi Medicaid eligibility is constantly changing for a woman based on her age and circumstance – what kinds of services she's seeking, as well as whether she's pregnant. Medicaid eligibility in Mississippi is among the strictest in the nation, with one exception – pregnant women. That means many low-income women only become eligible for Medicaid once pregnant. And since an application can take up to eight weeks to be processed, the chances that a woman in this situation will be able to use her newly acquired Medicaid insurance in the first trimester are slim. A law that would cut out this interim period and allow low-income pregnant women to be immediately seen by a doctor passed the Legislature in 2024, but was never implemented because of legislative errors. The policy went back through the Legislature in 2025, passed overwhelmingly again, but is not yet in effect. Some doctors already see women whose Medicaid application is pending, and the UMMC tool specifies at which clinics that's the case. Women of reproductive age seeking reproductive health care are also eligible for leniency in the typical Medicaid stipulations. These women can apply for a Medicaid family planning waiver, which allows them to access Medicaid for family planning purposes, even if they don't qualify for general Medicaid coverage. The income requirement for pregnancy Medicaid and the family planning waiver is a household income of less than 194% of the federal poverty level, or about $2,500 a month for one person in 2025. Dobbs, who has been the main point person on the project, said he hopes the online database is one more resource improving health care accessibility and women's health metrics in Mississippi. 'This isn't about getting patients to UMMC at all,' Dobbs said. 'It's about empowering patients to be able to get the care they need where they live.' ___ This story was originally published by Mississippi Today and distributed through a partnership with The Associated Press.


Gizmodo
32 minutes ago
- Gizmodo
‘Star Wars: Starfighter' Adds ‘Frankenstein' Star Mia Goth
As much as we'd love to see a Star Wars movie that just stars Ryan Gosling, Star Wars: Starfighter was never going to be that. He needs co-stars, aliens, droids, and now the very first of those may have come into view. The InSneider reports, and io9 has confirmed, that Mia Goth, the actress best known for her roles in Pearl, X, and MaXXXine, who'll soon appear Guillermo del Toro's Frankenstein and Christopher Nolan's The Odyssey, has been cast in the film. No word on what the role is, but reporter Jeff Sneider writes it is the same one Anora-star and Oscar-winner Mikey Madison was circling before moving along. This story is developing…


Medscape
36 minutes ago
- Medscape
A PCP Guide to Emerging Therapies for Resistant Hypertension
This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders . I'm Dr Matthew Frank Watto, here with my great friend and America's primary care physician, Dr Paul Nelson Williams. Paul, this is a topic you know a ton about, isn't it? Paul N. Williams, MD: It's one I always have questions about; I think this is our 37th episode on high blood pressure, if I'm not mistaken. Watto: The audience can't get enough of it — turns out, neither can I. Williams: Me neither! Watto: I love talking about high blood pressure, and this was with a great guest, Dr Jordy Cohen. She's a hypertension expert and a nephrologist. Paul, to start us off, what are we doing with blood pressure cuffs these days? Those manual ones on the wall, those are the way to go, right? Williams: This is a scenario we talk about all the time, and we've beat this drum a lot in prior episodes. I think we've all experienced a patient whose initial triage blood pressure reading is elevated, and either you or the patient will ask for a recheck and you're tempted to use a blood pressure cuff that's been hanging on the wall, has not been calibrated in 17 years, has a decaying spiral cord, and looks like it would fall apart if you touched it. Turns out that's probably not the best way to do it, Matt. So, to reiterate: Automated cuffs are the preferred option. They are more accurate. In this episode with Dr Cohen, we talked about making sure we use the appropriate cuff size and when we have patients who have large arms, you may have to use a wrist measurement every so often. In these circumstances, positioning matters: feet flat, back supported, elbow resting on a table, and have two fingers on the opposite clavicle so that everything is at heart level. If you're taking the blood pressure reading using a cuff around the arm itself, again, you should make sure the patient's arm is resting on a tabletop, bedside, or even on your own arm to ensure it's at heart level. You also shouldn't talk with the patient during that process so you can give them every chance to have an accurate blood pressure reading. That's the first thing: Get an accurate reading. Then everything else follows that step, as you should only treat a diagnosis that you've appropriately made. Watto: All the goals are based on a properly taken blood pressure, so if your patient's blood pressure hasn't been appropriately measured, you might overtreat or undertreat someone. For most patients who are nonfrail, we're now shooting for a blood pressure that is below 130/80 mm Hg. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for patients with chronic kidney disease state that normal blood pressure should be below 120/80, which is very hard to do. If we're getting people with a systolic in the 120s, that's probably about as good as we're going to get. For treatment, Dr Cohen and I have adopted this practice of using combination pills for hypertension management — either a calcium-channel blocker with an angiotensin-converting enzyme inhibitor or an angiotensin II receptor blocker (ARB). I usually prefer a calcium-channel blocker with an ARB or the 'triple pill,' a single-pill combination of a calcium-channel blocker, an ARB, and a diuretic. That's what I go to now as my first-line agent. I'm using a lot of either low-dose or medium-dose combination therapy. I don't usually go to the highest dose unless I'm in a situation where I have to decide between starting a fourth medication or going to a higher dose. That's really been a practice change for me. Dr Cohen reiterated that point and emphasized that it's easiest for the patient and they usually experience fewer side effects when you choose a low-to-moderate dose in comparison to a high dose. Williams: It's a point that we've made in prior episodes, as well. As you start to max out the doses of these medications, you get diminishing returns in terms of their efficacy in lowering blood pressure efficacy and patients can start to experience increased side effects. It's a far better option to start with a kind of median dose as opposed to really trying to crank up the dose, because you just don't get that much more benefit with that approach. Watto: We're going to discuss some of the newer blood pressure–lowering agents. Paul, the first one I want to ask you about is not quite a blood pressure medication, but it does lower blood pressure. Which medication am I talking about here? Williams: I think you're probably referring to semaglutide, Matt. I think we all have a fair amount of comfort with these diabetes and weight loss medications. These are remarkable medications and the indications keep piling on, which is great. Semaglutide, in particular, is not approved for hypertension, but it does lower blood pressure, likely as a result of the weight loss that is achieved with the medication. So, it's not technically an antihypertensive, but it provides a great blood pressure benefit. I think there's also some 'fancy pants' medications coming down the pipeline that we should probably be aware of, right? Watto: Yes, and the first one I'll mention is endothelin receptor antagonists. As a generalist, you're probably not going to be prescribing these; they will probably be prescribed by a hypertension specialist. Compared with placebo, they have a modest effect in lowering blood pressure (~4 mm Hg), but they are officially approved, so they're out there. What's more exciting, Paul, are aldosterone synthase inhibitors. The generic names for these include baxdrostat and lorundrostat. They're not yet approved, but I believe they are in phase 2 or phase 3 trials, depending on the indications. They seem promising, as they have a much stronger effect on blood pressure (~10-15 mm Hg) compared with placebo. Dr Cohen thinks these medications are probably going to be in the primary care wheelhouse soon. Cost will probably an issue with these medications at the start, but otherwise, these are pills that are taken once a day and they don't have the antiandrogen side effects that you can get with the mineralocorticoid receptor antagonists (MRAs), like spironolactone. Dr Cohen was really excited about being able to prescribe these at some point. Williams: And the MRAs are traditionally a fourth-line medication (unless you have compelling indications), so to have something else in your armamentarium that has less side effects is super exciting. It'll be great to see these in the pipeline. Watto: Now, what would you say, Paul, if I told you there was a medication for blood pressure that is only administered once every 6 months and will shut down the renin-angiotensin-aldosterone system (RAAS)? How does that sound? Williams: As someone who's taken medical school physiology, it sounds lightly terrifying! It feels like you do need the RAAS for some things, but I think for patients that are less interested in taking medications — which turns out to be most patients — it could potentially be exciting. I think as long as we have a way to reverse the effects of this medication if needed, then I think there's potential for excitement around this medication. Watto: I'm of course talking about a small interfering RNA (siRNA) agent. The one we talked about in this episode was zilebesiran; it's an siRNA agent and is administered once every 6 months. But no one would feel comfortable giving this unless there's an antidote, because if a patient gets septic, they probably need their RAAS to help them out there. Williams: Or if you have a patient who is pregnant — lots of reasons why you might actually want that system working. Watto: Exactly. Now, some people just don't want to take medications even if they need them, Paul. What else might be offered to a patient with high blood pressure? And how excited should we be about this next therapy? Williams: I feel like you're asking the wrong guy, Matt! I think you're alluding to renal denervation therapy. I feel it had a lot of wild enthusiasm initially, then it kind of waned, and now I feel like enthusiasm is back, baby — we're back into renal denervation. It sounds like a great option and I think we're doing a little better job with it, but its effect on lowering blood pressure is about equivalent to the effect you observe with a single-agent medication. So, realistically, these patients may still need to be on medications for blood pressure control. It's only effective for about two thirds of patients who get the procedure; that's 33% of your patients who would go through this invasive procedure where we're frying a nerve and in the end, they may not actually experience any blood pressure benefit. I think there's still a population that would benefit from and be interested in this option, but I don't think it's something that we should consider as first-line therapy for the majority of folks because of that potential for treatment failure and the continued need for medications among a substantial portion of the patients who undergo this procedure. It's still exciting that there's evidence for it and it does cause significant blood pressure lowering, so it's nice to have another option. Watto: Yeah, and I think patients are going be coming in and asking about it, so having some knowledge about the pros and cons of the procedure is important.